SCHEMBL19079675

SCHEMBL19079675

O=C(CSc1nc2sccc2c(=O)n1CC1CC1)c1cccs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.55
▸ HPGD P15428 3/20 0.55
▸ PDE4D Q08499 4/20 0.54
▸ NPSR1 Q6W5P4 4/20 0.53
▸ TSHR P16473 3/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ HTT P42858 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ POLB P06746 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ USP2 O75604 1/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ SLC22A12 Q96S37 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ HIF1A Q16665 2/20 0.44
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079770 0.87 PDE4D (0.71) ALDH1A1PDE4DNPSR1TSHRMAPK1
SCHEMBL19079694 0.84 PDE4D (0.76) ALDH1A1HPGDPDE4DNPSR1TSHR
SCHEMBL19079793 0.83 ALDH1A1 (0.78) ALDH1A1HPGDPDE4DNPSR1TSHR
SCHEMBL19079676 0.83 PDE4D (0.58) ALDH1A1PDE4DNPSR1TSHRSMN1; SMN2
SCHEMBL19079689 0.82 PDE4D (0.65) ALDH1A1HPGDPDE4DNPSR1TSHR
SCHEMBL19079720 0.80 PDE4D (0.77) ALDH1A1PDE4DNPSR1TSHRMAPK1
SCHEMBL19079728 0.77 PDE4D (0.76) ALDH1A1PDE4DNPSR1TSHRMAPK1
SCHEMBL19079684 0.71 ALDH1A1 (0.64) ALDH1A1HPGDPDE4DNPSR1TSHR
SCHEMBL19079691 0.70 PDE4D (1.00) ALDH1A1PDE4DNPSR1TSHRSMN1; SMN2
SCHEMBL19079774 0.70 ALDH1A1 (0.74) ALDH1A1HPGDPDE4DNPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A ALDH1A1 1503/4885HPGD 544/4885PDE4D 6/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A ALDH1A1 1503/4885HPGD 544/4885PDE4D 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback